Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.
Slate Medicines has emerged with hopes of cracking the code for delivering an injectable novel drug class to prevent ...
Influencers and celebrities are using unapproved peptide therapies. What does the science say about them?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results